Reduced serum ApoA-I levels correlate with the progression of lung, liver, breast, kidney, endometrial, and cervical cancer, associated with the appearance of metastases [99,107,123,124,125,127,137,141]. The gene discussed is APOA1; the disease is cervical carcinoma.